Compare PLAG & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAG | ACON |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Packaged Foods | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 7.5M |
| IPO Year | 2007 | 2022 |
| Metric | PLAG | ACON |
|---|---|---|
| Price | $0.70 | $2.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 636.8K | 43.8K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.56 | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,040,616.00 | $75,730.00 |
| Revenue This Year | N/A | $78.26 |
| Revenue Next Year | N/A | $90.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $0.49 | $1.95 |
| 52 Week High | $6.81 | $12.03 |
| Indicator | PLAG | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 49.50 |
| Support Level | $0.65 | $2.33 |
| Resistance Level | $0.77 | $2.50 |
| Average True Range (ATR) | 0.04 | 0.18 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 39.13 | 22.95 |
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.